Alliance Pharma Has High Hopes For Recovering Chinese Market in 2023
Executive Summary
Alliance Pharma is hopeful the end to COVID-19 movement restrictions in China will help to boost demand for its key consumer health brands Kelo-cote and Nizoral in 2023.